TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor. [electronic resource]
Producer: 20020723Description: 4257-65 p. digitalISSN:- 0950-9232
- Adenocarcinoma -- pathology
- Amino Acid Sequence
- Animals
- Antigen-Antibody Reactions
- Antigens, CD -- drug effects
- Antineoplastic Agents -- chemistry
- Apoptosis -- drug effects
- Binding Sites
- Biotransformation
- CHO Cells
- Coculture Techniques
- Colonic Neoplasms -- pathology
- Cricetinae
- Cricetulus
- Drug Design
- Humans
- Immunoglobulin Fragments -- chemistry
- Models, Molecular
- Molecular Sequence Data
- Prodrugs -- metabolism
- Protein Conformation
- Protein Structure, Tertiary
- Receptors, Tumor Necrosis Factor -- drug effects
- Receptors, Tumor Necrosis Factor, Type I
- Receptors, Tumor Necrosis Factor, Type II
- Recombinant Fusion Proteins -- genetics
- Rhabdomyosarcoma -- pathology
- Single-Chain Antibodies
- Tenascin -- chemistry
- Trypsin -- metabolism
- Tumor Cells, Cultured -- metabolism
- Tumor Necrosis Factor-alpha -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.